Categories
Health

How Republican Coronavirus Vaccine Opposition Bought to This Level

Republican lawmakers thanked her for theirs after Sherri Tenpenny, a doctor from the Cleveland area, mistakenly suggested during a hearing in the Ohio House of Representatives last month that Covid vaccines “magnetize” people and “interface” with 5G cell towers “Enlightenment”. Testimony.

In Congress, Republicans who once praised the Trump administration for its work to facilitate the rapid development of vaccines are campaigning vaccine misinformation that cast doubt on the Capitol’s safety and effectiveness.

And this week, Republican lawmakers in Tennessee successfully pressured health officials to end child outreach for all vaccines. The policy prohibits sending reminders of the second dose of a Covid vaccine to young people who have received a vaccination and communicating about routine vaccinations such as the flu shot.

A wave of opposition to Covid vaccines has risen within the Republican Party as conservative news outlets produce an ongoing diet of misinformation about vaccines and some GOP lawmakers invite vaccine conspiracy theorists to testify in state houses and Congress. With very little opposition from party leaders, these Republican efforts have brought falsehoods and doubts about vaccination off the fringes of American life into the focus of our political discussions.

It’s a pattern seen across the Trump administration: instead of blaming conspiratorial thinking and inaccuracies when it spreads within their party’s grassroots, many Republicans tolerate extremist misinformation.

Some Conservatives are spreading the falsehoods to rally their political base by taking up ideas like stolen elections, rampant electoral fraud, and revisionist history of the deadly siege of the Capitol. Many others say very little and prefer to evade questions from the news media.

Those who speak up remain reluctant to explicitly name colleagues who voiced misinformation or media personalities who did so, like Tucker Carlson of Fox News.

“As far as I know, we don’t control conservative media figures – at least I don’t,” Utah Republican Senator Mitt Romney recently told the New York Times. “That being said, I think it’s a huge mistake if someone suggests that we shouldn’t take vaccines.”

The anti-vaccination sentiment is not new to Republican voters. During the 2016 Republican primary, a number of candidates, including Donald J. Trump, reiterated theories that vaccines cause autism in children. It was around this time that Republican lawmakers began to oppose laws that tightened vaccination requirements for children.

But in recent months, change has accelerated within the party as some of Mr Trump’s supporters believe the national effort to promote Covid vaccination is harmful, unconstitutional, or perhaps even a sign of a shameful government conspiracy.

“Think about what these mechanisms could be used for,” said North Carolina MP Madison Cawthorn of the Biden administration’s plan to go door-to-door to reach millions of unvaccinated Americans, claiming without evidence, “They could then go door to door to take your guns with you. You could go door to door to take your Bibles with you. “

In a report earlier this month, the Kaiser Family Foundation found a widening vaccination gap between Republican and Democratic areas, with nearly 47 percent of people in counties President Biden-won being fully vaccinated, compared with 35 percent of people in Trump counties. In a recent Washington Post-ABC News poll, 47 percent of Republicans said they were unlikely to get vaccinated, compared with just 6 percent of Democrats.

As Covid cases rise across the country, almost all recent hospital admissions and deaths have occurred in unvaccinated people, White House officials said. While the national outlook remains much better than on previous uptrends, Vivek Murthy, the doctor general, issued his first recommendation to the Biden government this week warning of the “urgent threat” of health misinformation.

There is a tendency among Republican leaders to quietly – and sometimes not quite so quietly – attribute support for marginal beliefs and figures to Mr Trump. But when it comes to vaccinations, it’s hard to blame the former president.

Updated

July 17, 2021, 12:04 p.m. ET

Mr. Trump has eagerly recognized the accelerated development process of vaccines and urged Americans to get vaccinated. (He was tacitly given a vaccine before stepping down, however, rather than holding a public event for the shot, which might have encouraged his supporters to follow suit.) In an interview with Fox News last month, the former president said he made a statement “Very young people” concerned about the vaccination but said he was “still very convinced of what we did with the vaccine”.

“It’s amazing what we did,” he said. “You see the results.”

Other Republicans have not been quite as steadfast in echoing Mr Trump’s message on vaccines. Last year, Wisconsin Senator Ron Johnson praised Trump’s “brilliant” Operation Warp Speed. This year he made a number of dubious claims about side effects and deaths related to the vaccines.

In March, Georgia MP Marjorie Taylor Greene praised Mr. Trump for using the vaccines to save lives. That month, she urged Americans to “just say no” and used images from the Nazi era to criticize the Biden government’s efforts to reach unvaccinated people.

“People have a choice, they don’t need your medical tan shirts on their doorstep to order vaccinations,” she tweeted. “You can’t force people to be part of the human experiment.”

Less than a week later, Kentucky Senator Mitch McConnell, the Republican minority leader, encouraged Americans to get vaccinated, drawing on his experience as a childhood polio survivor.

“We have not one, not two, but three highly effective vaccines, so I am amazed at the difficulty we are having in getting the job done,” he said.

However, when asked by a reporter if part of the challenge came from the words of members of his own party, McConnell disagreed.

“I’ve already answered how I feel about it,” he said. “I can only speak for myself, and I only did that a few minutes ago.”

We want to hear from our readers. Have a question? We will try to answer them. Do you have a comment? We are listening. Email us at onpolitics@nytimes.com or send me a message on Twitter at @llerer.

… That’s roughly the amount deposited into American bank accounts this week for the nearly 60 million children eligible for the Extended Monthly Child Withholding Tax.

“I’m a sentimental person, don’t get me wrong,” Roland Mesnier, a former White House pastry chef, said in a recent interview. “Those were my babies.”

The Great Junk Purge is sweeping America.

Has this newsletter been forwarded to you? Sign up here to receive it in your inbox.

Thank you for reading. On Politics is your guide to the political news cycle and brings clarity out of the chaos.

Is there something you think we are missing? Would you like to see more? We’d love to hear from you. Send us an email at onpolitics@nytimes.com.

Categories
Health

Tennessee transfer to halt vaccine outreach to teenagers ‘extremely disturbing’

Director of the Centers for Disease Control and Prevention (CDC) Dr. Rochelle Walensky testifies during a Senate Appropriations Subcommittee hearing to examine the FY 2022 budget request for the Centers for Disease Control and Prevention on May 19, 2021 in Washington,DC.

Jim Lo Scalzo | AFP | Getty Images

Tennessee’s decision to cease vaccine outreach to teenagers while in the midst of a pandemic is “incredibly disturbing,” the head of the Centers for Disease Control and Prevention said Thursday.

“I find this incredibly disturbing. Not only is it disturbing for Covid, but it is disturbing for all vaccine-preventable illnesses,” CDC Director Dr. Rochelle Walensky said in an interview Thursday with CBS This Morning.

The state’s department of health reportedly decided to cease adolescent vaccine outreach for all vaccines, not just for Covid, effectively ending all government communication or education initiatives to teens in the state about vaccines.

The decision made headlines when the state’s medical director for vaccine-preventable diseases and immunization programs at the Tennessee Department of Health, Dr. Michelle Fiscus, was fired after she sent a memo to physicians outlining state policy that allows minors to seek medical care without parental approval.

Department spokesman Bill Christian said in a statement to CNBC that the state hasn’t halted its immunization program for children and continues to support “those outreach efforts. Providing information and access are routine public health functions, and that has not changed.”

He didn’t specifically say whether the state’s outreach program itself was halted.

The Tennessean, a newspaper in Nashville reported on Tuesday that it had gained access to internal reports and emails that instructs Tennessee Department of Health staff to subsequently strip the agency’s logo off of any disseminated vaccine education materials.

In another email that the Tennessean claims was sent from the agency’s Chief Medical Officer, Dr. Tim Jones, he told staff they should do “no proactive outreach regarding routine vaccines.” Staff was also reportedly told not to do any pre-planning for flu shots events at schools. In the emails, Jones reportedly said that any school-related vaccine information should come from the state’s Department of Education.

The newspaper also claims that internal documents reportedly indicate that the agency was directed by Health Commissioner Dr. Lisa Piercey to halt all Covid vaccine events on school property and to no longer send postcards or other notices reminding adolescents to return for their second doses of Covid shots.

On Thursday, the agency released a statement labeling the circulating reports as misinformation. “There has been no disruption to the childhood immunization program or access to the Covid-19 vaccine while the department has evaluated annual marketing efforts intended for parents,” Piercey said in the statement.

The statement does not address reports that the agency halted vaccine outreach for adolescents.

Fiscus said she began to feel the pressure after she highlighted a public document from a state Supreme Court case ruling that allows residents above the age of 14 to seek medical treatment without the consent of a parent “unless the physician believes that the minor is not sufficiently mature to make his or her own health care decisions,” according to the ruling.

“I am not a political operative, I am a physician,” Fiscus told MSNBC. She said she was told she was “poking the bear” and that she needed to work on her political awareness after publicizing the public document. Republican lawmakers likened the state’s adolescent vaccine outreach to peer pressure, she said.

Tennessee has one of the worst Covid vaccination rates in the country, fully immunizing just 38% of its total population, according to CDC data. The state is also seeing increasing Covid cases, with the average number of daily new cases spiking from 177 to 418 in just the past two weeks.

“We now have our most hesitant population being rural male conservative whites, who really do hang their hat on this political ideology that Covid-19 isn’t real, isn’t a threat, or that getting the vaccine somehow props up the left-wing part of our political system,” she told MSNBC.

The state and others with low vaccination rates are starting to see cases climb as the delta variant takes hold in the U.S.

“This is something that we anticipated … that we would see in areas of high vaccination, low case rates, and now we see in areas of low vaccination, high case rates,” Walensky said.

Walensky said a spike in infections could come in the next few months but that if more people get vaccinated now, the nation can “prevent what could happen in the fall.”

Correction: A previous version of the headline misquoted Dr. Rochelle Walensky.

Categories
Health

Not prudent to deploy vaccine boosters at this level: Ex-FDA director

There is currently insufficient evidence that Covid vaccine booster shots are required, according to a former FDA director.

“It is a good thing to be prepared to make boosters, but we really don’t have … evidence, at least in the United States, where we’re seeing vaccine failures or a decrease in immunity, so it’s time to put a booster on “said Norman Baylor, who previously worked for the US Food and Drug Administration’s Vaccine Research and Review Bureau.

Pharmaceutical company Pfizer is developing a Covid booster, or third dose, to combat the highly transmissible Delta variant, which has become the dominant strain in many countries, including the United States

The Centers for Disease Control and Prevention and the FDA said in a joint statement last week that “Americans who have been fully vaccinated currently do not need a booster dose”.

Pfizer met with U.S. officials Monday to plead for a third shot.

The company worked with German company BioNTech to develop a vaccine consisting of two doses given three weeks apart. In December it received emergency approval from the World Health Organization.

No significant vaccination failure

The vaccine errors are currently very small with the vaccines currently in use. Until that changes, I don’t think it would be advisable to give a booster dose.

Norman Baylor

CEO of Biologics Consulting

Westbury, NY: A man receives the Moderna COVID-19 vaccine while at the Long Island State Qualified Health Center in Westbury, New York on April 29, 2021. (Photo by Steve Pfost / Newsday via Getty Images)

Steve Pfost | News day | Getty Images

He said health officials seem to agree that a third dose is not required.

“We’re just not there yet … we have no evidence that it is time to get a booster,” he said, adding that there may be new variations in the future that make current vaccines ineffective or much less effective.

Vaccination inequality

Richer countries have been able to vaccinate a large part of their population, while poorer countries lag behind.

The issue of vaccine disparity between regions needs to be addressed, Baylor said.

“A pandemic itself, the definition is that it is global,” he said, adding that he agreed with the World Health Organization that the crisis must be viewed from a global perspective.

Some countries and regions are actually ordering millions of booster doses before other countries have had supplies to vaccinate their health workers and those most at risk.

Tedros Adhanom Ghebreyesus

Director General, World Health Organization

WHO director general Tedros Adhanom Ghebreyesus said Monday the world is “in the midst of a growing two-pronged pandemic”.

“Some countries and regions are actually ordering millions of booster doses before other countries have had supplies to vaccinate their health workers and the most vulnerable,” he said during a press conference, adding that the world Make “conscious choices” so as not to protect those most in need.

The data suggest the vaccines offer long-lasting immunity to severe and deadly Covid-19, he said.

“The priority now must be to vaccinate those who have received no doses and no protection,” said the WHO chief.

Biotech companies such as Pfizer-BioNTech and Moderna, which have developed another mRNA vaccine against Covid-19, must “give everything” to direct supply to the places in need, including through the Covax vaccine distribution alliance, he added.

Categories
Health

Homeopathic Physician Is Charged With Promoting Pretend Covid-19 Vaccine Playing cards

A homeopathic doctor in California is the first person to be charged by the federal government for selling fake Covid-19 vaccination cards, authorities said.

The doctor Juli A. Mazi from Napa, California, also sold Covid-19 “vaccine pellets” to patients, the federal prosecutor said. She was arrested on Wednesday and charged with wire fraud and false testimony regarding health matters, according to a criminal complaint. Ms. Mazi could face up to 20 years in prison and hundreds of thousands of dollars in fines, authorities said.

Ms. Mazi sold pellets for $ 243, which she said contained a “very tiny amount” of the coronavirus that would trigger an immune response and provide “lifelong immunity to Covid-19,” the complaint said. To encourage customers to buy the pellets, prosecutors said Ms. Mazi falsely told them that the three Covid-19 vaccines approved for use in the US contained “toxic ingredients.”

It also offered homeopathic vaccinations for childhood diseases that it falsely claimed would meet vaccination requirements for California schools, the complaint said.

Ms. Mazi was not immediately available for comment. It wasn’t immediately clear whether she had a lawyer.

She describes herself on her website as a naturopathic doctor who received her PhD from the National University of Natural Medicine in Portland, Oregon. She is trained in “traditional medical sciences” and “ancient and modern modalities” that nature says use for healing.

It also offers “classic homeopathy”, a medical system developed in Germany more than 200 years ago. It uses the theory that a substance can be cured by a substance that causes similar symptoms and the notion that drugs are more effective at minimal dosages, according to the National Center for Complementary and Integrative Health. There is little evidence that homeopathy is an effective treatment for disease, the center said, citing a 2015 assessment by Australia’s National Health and Medical Research Council. A number of concepts in homeopathy are inconsistent with basic scientific concepts agreed, said the center.

Authorities began investigating Ms. Mazi after someone filed a complaint in April that relatives bought her the Covid-19 vaccine tablets and had not received any of the approved Covid-19 vaccinations. In addition to the pellets, Ms. Mazi also sent the family’s Covid 19 vaccination cards, on which Moderna was listed, according to the prosecutor. She instructed them to mark the cards to falsely indicate that they received the vaccine on the day they ingested the pellets.

It is unclear how many people bought Covid-19 vaccine pellets from Ms. Mazi, but she received more than $ 200,000 through Square, a digital payment processing company, from January 2020 to May 2021, the complaint said. Most of the transactions did not specify the purpose of the payments, but 25 transactions worth more than $ 7,500 were recorded to indicate that the complaint was for Covid-19 treatments.

“This defendant allegedly betrayed and endangered the public by exploiting fears and spreading misinformation about FDA-approved vaccinations while selling counterfeit treatments that put people’s lives at risk,” said Lisa O. Monaco, assistant attorney general , in a statement. She added that using false vaccination cards allowed people to “bypass efforts to contain the spread of the disease”.

Steven J. Ryan, special envoy for the inspector general’s office for the Department of Health and Human Services, said the department will continue to investigate “scammers” who are misleading the public.

“This doctor has violated the important public trust in health professionals at a time when integrity is most needed,” he said in a statement.

In May, California authorities arrested the owner of a bar on charges of selling fake Covid-19 vaccination cards in his shop. There is also concern that people who share photos of their vaccination card with their name and date of birth could leave them at risk of identity theft or fraud.

Categories
Health

F.D.A. Attaches Warning of Uncommon Nerve Syndrome to Johnson & Johnson Covid Vaccine

The database shows only one possible death of a recipient of the Johnson & Johnson shot from Guillain-Barre Syndrome. But the man, a 57-year-old Delaware man, had also suffered a heart attack and stroke in the past four years, which raised questions about his April death.

Although it only requires a single dose and is easier to store than Pfizer and Moderna vaccines, Johnson & Johnson vaccination played only a minor role in the US vaccination campaign. One of the reasons for this is that a plant in Baltimore that was supposed to supply most of the cans in the country was closed for three months for violating the law. The factory, operated by Emergent BioSolutions, a subcontractor, was forced to discard the equivalent of 75 million cans on suspicion of contamination, significantly delaying deliveries to the federal government.

At the same time, demand for the shot collapsed after the safety break in April. At that time, 15 women in the United States and Europe who received the Johnson & Johnson injection were diagnosed with the coagulation disorder; three died. The CDC has now confirmed 38 cases of the disorder.

Regulatory authorities and federal health officials warned that women under the age of 50 in particular should be aware of the “rare but increased” risk of clotting. In the nearly three months since the hiatus ended, only about five million people in the U.S. have taken Johnson & Johnson’s recording, and state officials report that people are much more cautious. Millions of cans distributed by the federal government sit unused and expire this summer.

Alex Gorsky, CEO of Johnson & Johnson, said last month he was still confident that the vaccine, which has been used in 27 countries, will help contain the pandemic overseas. The company has pledged up to 400 million cans to the African Union. Regardless, Covax, the global vaccine exchange program, is set to receive hundreds of millions of doses.

Studies have shown that the Johnson & Johnson syringe protects people from more contagious variants of the coronavirus, including the Delta variant, and is highly effective in preventing severe Covid-19, hospitalizations, and death.

The Food and Drug Administration shares responsibility for vaccines with the CDC, but is solely responsible for issuing product warnings. The Guillain-Barré cases will be discussed at an upcoming meeting of a committee of external experts advising the CDC, the agency said.

Categories
Health

F.D.A. Will Connect Warning of Uncommon Nerve Syndrome to Johnson & Johnson Vaccine

The Food and Drug Administration is planning to warn that Johnson & Johnson’s coronavirus vaccine can lead to an increased risk of a rare neurological condition known as Guillain–Barré syndrome, another setback for a vaccine that has largely been sidelined in the United States because of manufacturing problems and a temporary safety pause earlier this year, according to several people familiar with the plans.

Although regulators have found that the chances of developing the condition are low, they appear to be three to five times higher among recipients of the Johnson & Johnson vaccine than among the general population in the United States, according to people familiar with the decision.

Federal officials have identified roughly 100 suspected cases of Guillain-Barré disease among recipients of the Johnson & Johnson shot through a federal monitoring system that relies on patients and health care providers to report adverse effects of vaccines. The reports are considered preliminary. Most people who develop the condition recover.

The F.D.A. has concluded that the benefits of the vaccine in preventing severe disease or death from the coronavirus still very much outweigh any danger, but it plans to include the proviso in fact sheets about the drug for providers and patients

“It’s not surprising to find these types of adverse events associated with vaccination,” said Dr. Luciana Borio, a former acting chief scientist at the F.D.A. under President Barack Obama. The data collected so far by the F.D.A., she added, suggested that the vaccine’s benefits “continue to vastly outweigh the risks.”

In a statement released Monday, the Centers for Disease Control and Prevention said the cases have largely been reported about two weeks after vaccination and mostly in males, many aged 50 years and older.

The database reports indicate that symptoms of Guillain-Barré developed within about three weeks of vaccination. One recipient, a 57-year-old man from Delaware who had suffered both a heart attack and a stroke within the last four years, died in early April after he was vaccinated and developed Guillain-Barré syndrome, according to a report filed to the database.

The Biden administration is expected to announce the new warning as early as Tuesday. European regulators may soon follow suit. No link has been found between Guillain-Barré syndrome and the coronavirus vaccines developed by Pfizer-BioNTech or Moderna, the other two federally authorized manufacturers. Those rely on a different technology.

Nearly 13 million people in the United States have received Johnson & Johnson’s shot, but 92 percent of Americans who have been fully vaccinated received shots developed by Pfizer-BioNTech or Moderna. Even though it requires only one dose, Johnson & Johnson’s vaccine has been marginalized by manufacturing delays and a 10-day pause while investigators studied whether it was linked to a rare but serious blood clotting disorder in women. That investigation also resulted in a warning added to the fact sheet.

The new safety concern comes at a precipitous moment in the nation’s fight against Covid-19. The pace of vaccinations has slowed considerably just as a new, more contagious variant called Delta is spreading fast in under-vaccinated areas. Federal health officials are worried that the news could make some people even more hesitant to accept the vaccines developed by Pfizer-BioNTech or Moderna, even though well over 100 million people have received those vaccines, according to the Centers for Disease Control and Prevention.

Updated 

July 12, 2021, 2:12 p.m. ET

Almost one-third of the nation’s adults remain unvaccinated. The Biden administration has shifted away from relying on mass vaccination sites and is now enlisting community workers in door-to-door campaigns, supplying doses to primary care doctors and expanding mobile clinics in an attempt to convince the unvaccinated to accept shots.

Johnson & Johnson’s vaccine has played a minor role in the nation’s inoculation campaign partly because the Baltimore plant that was supposed to supply most of the doses to the United States has been shut down for three months because of regulatory violations. The factory, operated by Emergent BioSolutions, a subcontractor, has been forced to throw out the equivalent of 75 million doses because of suspected contamination, severely delaying deliveries to the federal government.

Demand for the shot also plummeted after the April safety pause. At that time, 15 women in United States and Europe who had received the Johnson & Johnson shot had been diagnosed with the disorder. Three had died.

Regulators ultimately decided that the risk was remote and far outweighed by the benefits. They attached a warning to the drug and cleared it for use, but state officials have said that the perception that the vaccine might be unsafe hurt it.

Alex Gorsky, Johnson & Johnson’s chief executive, said last month that he was still hopeful that the vaccine, which has been used in 27 countries so far, would help contain the pandemic overseas. The company has promised up to 400 million doses to the African Union. Separately, Covax, the global vaccine-sharing program, is supposed to receive hundreds of millions of doses.

Studies have showed that the Johnson & Johnson shot protects people against more contagious virus variants, including the Delta variant, and is highly effective at preventing severe Covid-19, hospitalizations and death.

The F.D.A. shares jurisdiction over vaccines with the Centers for Disease Control and Prevention but is responsible for issuing product warnings. The Guillain-Barré cases are expected to be discussed in an upcoming meeting of a committee of outside experts who advise the C.D.C.

The F.D.A. has also attached a warning to the Pfizer-BioNTech and Moderna vaccines, but some health officials described that as less serious than the warnings about Johnson & Johnson. Last month, the agency warned about an increased risk of inflammation of the heart or the tissue surrounding it — diseases known as myocarditis and pericarditis — particularly among adolescents and young adults who had received Pfizer-BioNTech or Moderna shots. But the C.D.C. said in most cases, symptoms promptly improved after simple rest or medication.

The Guillian-Barré syndrome is more likely to result in medical intervention, officials said. It occurs when the immune system damages nerve cells, causing muscle weakness and occasional paralysis, according to the F.D.A. Several thousand people — or roughly 10 out of every one million residents — develop the condition every year in the United States. Most fully recover from even the most severe symptoms, but in rare cases patients can suffer near-total paralysis.

The suspected cases were reported in the Vaccine Adverse Event Reporting System, or VAERS, a 30-year-old federal monitoring system. So far, researchers have not identified any particular demographic pattern, but the many of the reports in the publicly available database indicate that the patients were hospitalized.

Guillain-Barré syndrome has also been linked to other vaccines. The Centers for Disease Control and Prevention has said that flu vaccines, including the 1976 swine flu vaccine, led to a small increased risk of contracting the syndrome, although some studies suggested that people are more likely to develop Guillain-Barré from the flu itself than from flu vaccines. Earlier this year, the F.D.A. warned that GlaxoSmithKline’s shingles vaccine, Shingrix, could also increase the risk of the disease.

Only about five million people in the U.S. have taken Johnson & Johnson’s shot since the April pause was lifted. Millions of doses that have been distributed by the federal government are sitting unused and will expire this summer.

Apoorva Mandavilli and Carl Zimmer contributed reporting.

Categories
Health

Citing the Delta Variant, Pfizer Will Pursue Booster Pictures and a New Vaccine

Pfizer and BioNTech announced Thursday that they are developing a version of the coronavirus vaccine that will target Delta, a highly contagious variant that has spread to nearly 100 countries. The companies expect to begin clinical trials of the vaccine in August.

Pfizer and BioNTech also reported promising results from studies of people who received a third dose of the original vaccine. A booster shot six months after the second dose of the vaccine increases the effectiveness of the antibodies against the original virus and beta variant by five to ten-fold, the companies say.

The vaccine’s effectiveness could decline six months after immunization, the companies said in a press release, and booster doses may be needed to fight off virus variants.

The data were neither published nor peer-reviewed. The vaccine manufacturers said they expected to submit their results to the Food and Drug Administration in the coming weeks, a step toward approval for booster shots.

But the companies’ claims contradict other research, and several experts dismissed the claim that boosters are needed.

“Given the variants currently circulating, there is really no evidence of a third booster or a third dose of an mRNA vaccine,” said Dr. Celine Gounder, an infectious disease specialist at Bellevue Hospital Center in New York. “In fact, many of us wonder if you’ll ever need boosters.”

Federal authorities also sounded dubious on Thursday night. In general, Americans who have been fully vaccinated currently do not need a booster vaccination, the FDA and the Centers for Disease Control and Prevention said in a joint statement.

“We are prepared for booster doses when science shows they are needed,” the authorities said.

The Delta variant, first identified in India, is believed to be about 60 percent more contagious than Alpha, the version of the virus that ripped through the UK and much of Europe earlier this year, and perhaps twice as contagious as the original coronavirus.

The delta variant is now causing outbreaks among unvaccinated populations in countries like Malaysia, Portugal, Indonesia and Australia. In the USA, too, Delta is now the dominant variant, the CDC reported this week.

Until recently, infections in the US were at their lowest level since the pandemic began. Hospital stays and deaths related to the virus have continued to decline, but new infections could increase.

It is not yet clear to what extent the variant is responsible for this; A slower vaccination campaign and quick reopenings also play a role.

Citing data from Israel, Pfizer and BioNTech suggest that the effectiveness of their vaccine “in preventing infections and symptomatic illnesses decreased six months after vaccination.” Given the surge in Delta and other variants, the companies said “a third dose may be required within 6 to 12 months of full vaccination”.

Updated

July 11, 2021 at 1:57 p.m. ET

Health officials in Israel have estimated that full vaccination with the Pfizer BioNTech is only 64 percent effective against the Delta variant. (It is more than 90 percent effective against the original virus.)

But Israel’s estimates have been disproved by a number of other studies which found the vaccine to be very effective at preventing infection – against all variants. For example, a recent study showed that mRNA vaccines like those from Pfizer trigger a sustained immune response in the body that can protect against the coronavirus for years.

“Pfizer is looking opportunistic by putting an announcement on the back of very early and undigested data from Israel,” said John Moore, a virologist at Weill Cornell Medicine in New York. “When the time comes to use boosters here, the decision is not up to you.”

The companies described their plan to develop a new vaccine against Delta as a kind of backup measure in case the original vaccine replenishment fails. The new vaccine targets all of the spike protein, not a portion, and the first batch has already been made.

The delta variant poses challenges for the immune system. In the journal Nature on Thursday, French researchers reported new evidence that the delta variant can partially bypass the body’s immune response, as changes to the spike protein on its surface make it difficult for antibodies to attack.

The team analyzed blood samples from 59 people after they received the first and second doses of the vaccine. Blood samples from just 10 percent of those immunized with a dose of the AstraZeneca or Pfizer-BioNTech vaccines were able to neutralize the Delta and Beta variants in laboratory tests.

“A single dose of Pfizer or AstraZeneca was either poorly effective or not effective at all against beta and delta variants,” the researchers concluded. Data from Israel and the UK largely support this finding, although those studies also suggested that one dose of vaccine was still enough to prevent hospitalization or death from the virus.

But a second dose increased the effectiveness to 95 percent. There was not much difference in the levels of antibodies produced by the two vaccines.

“When you receive two doses of an mRNA vaccine, you are very well protected against serious illness, hospitalization and death for each of the variants,” said Dr. Gounder.

The researchers also looked at blood samples from 103 people infected with the coronavirus. Delta was much less sensitive than Alpha to samples from unvaccinated individuals in this group, the study found.

One dose of vaccine increased sensitivity significantly, suggesting that people who have recovered from Covid-19 may still need to be vaccinated to fight off some variants.

Taken together, the results suggest that two doses of the vaccine provide strong protection against all variants, as does one dose for people who have recovered from Covid-19 and have some natural immunity.

Some experts also questioned discussions about boosters for Americans while much of the world has not yet received a single dose.

“It’s impossible to ignore the global situation,” said Natalie Dean, biostatistician at Emory University in Atlanta. “I find it hard to imagine getting a third dose when there are front line workers treating Covid patients who have not yet been vaccinated.”

Every unvaccinated person offers the virus additional opportunities to mutate into dangerous variants, said Dr. Gounder feast.

“If we are concerned about variants,” she said, “our best protection is to get the rest of the world vaccinated, and not to hoard more doses to give people here in the US third doses of mRNA vaccines. “

Categories
Health

Biden’s new Covid vaccine push focuses on employees, college students, delta variant

President Joe Biden on Tuesday once again pushed for all eligible Americans to get Covid vaccinations, stressing the importance of being protected against the highly transmissible delta variant.

Despite the U.S. being on track to hit 160 million people fully vaccinated in the coming days, Biden said, millions remain unvaccinated against Covid, “and because of that, their communities are at risk, their friends are at risk, the people they care about are at risk.”

“This is an even bigger concern because of the delta variant,” the president said.

“It seems to me, this should cause everybody to think twice,” Biden said. But “the good news is that our vaccinations are highly effective,” including against the delta variant, he added.

Biden detailed his administration’s latest push to increase vaccination rates two days after failing to reach his Covid vaccination goal for the Fourth of July.

His team is now training its focus on boosting vaccination availability in places such as doctor’s offices and work settings. They are also ramping up efforts to get vaccines to pediatricians and other child health-care providers, Biden said, with the goal of getting more adolescents ages 12 to 18 inoculated before they head back to school in the fall.

The team also aims to expand mobile clinic efforts and will work to refine door-to-door outreach efforts to get information about vaccines to Americans who have yet to get their shots, the president said.

“Our focus now is on doubling down on our efforts” to get more people vaccinated, White House press secretary Jen Psaki said at a briefing earlier Tuesday afternoon.

“There’s still more work to be done,” Psaki said, before noting that “the vast, vast majority of people are safe from the virus” once they are vaccinated.

“If you are not vaccinated, you are not. That is also a message that we’re going to continue to clearly communicate,” she said.

Biden in his speech at the White House highlighted that nearly 160 million people in the U.S. will be fully vaccinated by the end of this week.

There are currently 157 million people in the U.S. who are fully vaccinated, which is less than half of the total population, according to Centers for Disease Control and Prevention data. Among people in the U.S. ages 18 and up, the CDC’s percentage for those fully vaccinated rises to 58.2%, and it stands at 78.7% among those ages 65 or older, who face the greatest risk from Covid.

Biden in May had set the goal of having 70% of American adults vaccinated with at least one shot by Independence Day. On the holiday itself, roughly 67% of U.S. adults had received at least one dose, according to the CDC.

“The bottom line is, the virus is on the run and America’s coming back, coming back together,” Biden said. It’s “one of the greatest achievements in American history,” he said, “but our fight against the virus is not over.”

The delta variant, which was first observed in India, has now spread to at least 96 countries, including the U.S., according to the World Health Organization.

The variant, which the WHO says is about 55% more transmissible than another strain of the virus found in the United Kingdom, has threatened to derail some countries’ plans to lift social-distancing restrictions. About 25% of all new reported U.S. Covid cases are of the delta variant, according to the CDC, which predicts it will become the dominant variant.

White House chief medical advisor Dr. Anthony Fauci last month called delta the “greatest threat” to the nation’s fight against the pandemic.

Dr. Scott Gottlieb, the former commissioner of the Food and Drug Administration, told CNBC last week that while the delta variant may cause an increase in cases, he doesn’t expect a massive surge in infections on the scale of those seen at earlier points in the pandemic.

“I don’t think it’s going to be a raging epidemic across the country like we saw last winter. I think that there’s going to be pockets of spread, and prevalence overall is going to pick up,” Gottlieb said on “Squawk Box.” 

The White House is deploying Covid-19 response teams across the nation focused on combatting the variant. The teams, composed of officials from the CDC and other federal agencies, will work with communities at higher risk of experiencing outbreaks.

There are still about 1,000 counties in the U.S. that have vaccination coverage of less than 30%, CDC Director Dr. Rochelle Walensky told reporters last week.

The counties are mostly located in the Southeast and Midwest and the agency is already seeing increasing rates of disease in these places due to further spread of the delta variant, she said.

— CNBC’s Ylan Mui contributed to this report.

Disclosure: Scott Gottlieb is a CNBC contributor and is a member of the boards of Pfizer, genetic testing start-up Tempus, health-care tech company Aetion Inc. and biotech company Illumina. He also serves as co-chair of Norwegian Cruise Line Holdings’ and Royal Caribbean’s “Healthy Sail Panel.”

Categories
World News

Covid-19 and Vaccine Information: Reside Updates

Here’s what you need to know:

Credit…Pool photo by Frank Augstein

Prime Minister Boris Johnson said Monday that the government will likely lift most remaining Covid restrictions in England on July 19, and that he would likely leave it up to people to decide whether to keep wearing masks in subways, buses, and other confined spaces.

Mr. Johnson detailed plans for lifting the restrictions and loosening some travel rules at a news conference on Monday evening, stressing that a final decision on ending most pandemic limits would be made on July 12.

The announcement was met with both hope and trepidation. Although emerging variants have caused the number of infections in the country to rise in recent weeks, so far that has yet to be followed by a commensurate rise in hospital admissions or deaths — a sign Mr. Johnson and his advisers said that the vaccines are working.

“There’s only one reason why we can contemplate going ahead to Step 4 in circumstances where we’d normally be locking down further and that’s because of the continuing effectiveness of the vaccine rollout,” Mr. Johnson said.

Ahead of his address, Mr. Johnson had said people in the country had to “learn to live with this virus.”

And Monday evening, Mr. Johnson said beginning the July 19, the government will “move away from legal restriction and allow people to make their own decisions on how to manage the virus.”All businesses will be allowed to open. Social distancing and face coverings will no longer be mandatory, though, Mr. Johnson said there would be guidance for people who may wish to wear masks. Working from home guidance will no longer be in place.

The full reopening had been scheduled to take place last month, but was delayed because of worries over the more contagious Delta variant. The number of infections in the country has risen in recent weeks — primarily among younger people, who have only recently become eligible for vaccination. But 86 percent of adults in England have received at least one vaccine dose, among the highest rates in the world.

Organizers of nightlife and live events, which have largely fallen silent during the pandemic, had lobbied against further delays. Though many venues remain closed, Wembley Stadium will host the semifinals and finals of the European Championship soccer tournament in the coming days, with as many as 60,000 people allowed to attend if they show proof of vaccination or a negative virus test.

There are concerns, however, that the large gatherings will lead to further outbreaks. More than 2,000 people in Scotland tested positive for the virus last week after watching a Euro 2020 game at a stadium, fan zone or pub, according to National Health Scotland — nearly two-thirds of which were linked to a Euro 2020 game in London.

With England’s full reopening, restaurants and pubs will be able to serve more patrons, and limits on gatherings like weddings will be removed.

Britain reported over 24,000 new daily cases on Sunday, the highest number since early February, though the rates of hospitalizations and deaths remain low. And medical experts had urged officials to maintain some regulations, including mandatory face coverings and guidance on social distancing.

“It’s not a binary decision of all or nothing,” said Dr. Chaand Nagpaul, the chair of the British Medical Association Council, adding that such measures would minimize the impact of rising infections.

England has accelerated efforts to vaccine younger people in recent weeks, and officials said they were working on a program to offer booster shots to people over 50 and other vulnerable people this coming winter.

Scotland, Wales and Northern Ireland are working on separate, though similar timelines to also fully reopen the economy in their nations.

President Biden said on Sunday that getting vaccinated against the coronavirus was “the most patriotic thing” that Americans could do. In remarks addressed to a crowd attending a Fourth of July party on the White House’s South Lawn, and broadcast nationally, he said the United States was emerging from the darkness of the pandemic but stressed that the country was not yet fully clear of it.

He singled out the Delta virus variant as a particular threat.

Mr. Biden had hoped to turn the Fourth of July into a celebration not just of the nation’s independence, but also of reaching his administration’s ambitious goal to have 70 percent of adults at least partly inoculated against the coronavirus before the holiday.

He didn’t quite make it. As of Friday, about 67 percent of people in the country 18 and older had gotten at least one vaccine dose, according to a New York Times tracker. Almost 60 percent of adults were fully vaccinated, and the highly contagious Delta variant was creating hot spots, particularly in states with low vaccination rates, like Missouri.

The shortfall did not dampen the White House’s outlook. The president had pressed ahead with an optimistic message, signaling that this year’s July Fourth celebration would be about “independence from the virus” and a return to some semblance of normal life.

On Saturday, Mr. Biden visited Traverse City, Mich., as part of what the White House called the “America’s Back Together” celebration. On Sunday, he and his wife, Jill Biden, hosted a party whose invitation list included 1,000 military personnel and essential workers, on whom Mr. Biden lavished thanks during his speech.

A sense of a new day seems to be shared by many Americans, who returned to prepandemic Fourth of July rituals in droves, flocking to the roads and the skies in the stiffest test yet for the nation’s travel infrastructure since the pandemic mostly shut it down in March 2020.

The Transportation Security Administration screened 2.197 million people on July 3, the most since March 5, 2020, about a week before the World Health Organization declared a pandemic.

Despite the new variant’s spread, reports of new cases across the country have been holding steady at 12,000 a day, the lowest since testing became widely available. The U.S. average of fewer than 300 daily deaths from Covid-19 is a decline of 23 percent over the past two weeks. Hospitalizations are also dropping.

Some public health experts cautioned, however, that scenes of celebrations might send the wrong message when wide swaths of the population remain vulnerable.

The continuing threat was brought into sharp focus on Saturday when the authorities announced that six emergency medical workers helping with rescue efforts at the site of a collapsed condo in Surfside, Fla., had tested positive.

On Friday, Mr. Biden urged people who have yet to get vaccinated to “think about their family” and get a shot as the Delta variant spreads.

“I am concerned that people who have not gotten vaccinated have the capacity to catch the variant and spread the variant to other people who have not been vaccinated,” he said. “Don’t just think about yourself.”

An employee wearing a mask at a restaurant in New York last month while patrons were free to go without face coverings..Credit…Sara Messinger for The New York Times

In the weeks since the Centers for Disease Control and Prevention revised its mask guidelines to allow fully vaccinated people to take their masks off in most indoor settings, a stark divide has emerged, particularly in wealthier enclaves where services are at a premium.

Those still wearing masks tend to be members of the service class — store clerks, waiters, janitors, manicurists, security guards, receptionists, hair stylists and drivers — while those without face coverings are often the well-to-do customers being wined and dined.

Employers are hesitant to discuss their mask policies, but there are sensible reasons for requiring staffers to keep their masks on.

Just under 50 percent of people in the United States are fully vaccinated. And coronavirus variants, some of which are highly infectious and may be more resistant to vaccines, are on the rise, said Dr. Lisa Maragakis, an epidemiologist and associate professor at Johns Hopkins University.

Food servers, retail clerks, grocery cashiers and other public-facing workers interact all day with customers, which can put their health (and the health of their customers) at risk. This creates not only potential liability issues for employers, but also could hamstring a business at a time of worker shortages.

Even at establishments that give vaccinated employees the choice to take their masks off, many are keeping them on. “Who knows who has had their shot and who hasn’t,” said Michelle Booker, a store clerk from the Bronx who works at a Verizon store in Midtown Manhattan.

An overnight vaccination drive for people on the margins of society, called Open Night, in Rome on Saturday.Credit…Giuseppe Lami/EPA, via Shutterstock

Nearly 900 people tried to take advantage of an overnight vaccination drive, called Open Night, over the weekend in an inoculation effort organized by the health authorities in the Lazio region of Italy, which includes Rome.

The initiative, organized in a cloister of the Santo Spirito hospital, near the Vatican, was targeted at “people on the margins of society, the most fragile,” said Angelo Tanese, the director general of ASL Roma 1, the region’s largest local health unit.

To help draw in the crowds, a jazz pianist serenaded those present on Saturday night, while free espresso and cornetti — Italian croissants — were offered on Sunday morning.

Doctors and nurses administered the Johnson & Johnson vaccine to homeless people, undocumented migrants, foreign students and foreigners who legally work in Rome but are not registered with the national health service.

Johnson & Johnson’s vaccine, which requires only one dose — unlike the two-shot regimens made by AstraZeneca, Moderna and Pfizer-BioNTech — is especially useful for inoculating people who may be harder to reach or may not return for a second dose. About 80 percent of the people at the Santo Spirito clinic were undocumented migrants, Mr. Tanese said.

As of Sunday, nearly 20 million people in Italy had been fully vaccinated — about 32 percent of the total population.

A protest including stagehands in front of he Metropolitan Opera in New York in May.Credit…Angela Weiss/Agence France-Presse — Getty Images

The Metropolitan Opera has reached a tentative agreement for a new contract with the union that represents its stagehands, increasing the likelihood that the company will return to the stage in September after its longest shutdown ever.

The company’s roughly 300 stagehands were locked out late last year because of a disagreement over how long and lasting pandemic pay cuts would be. But the opera house is in desperate need of workers to prepare its complex operations if it is to reopen in less than three months.

Pressure on the talks had increased as the two sides negotiated for nearly four weeks.

The Met, which says it has lost more than $150 million in revenue since the pandemic forced it to close in March 2020, has asked for significant cuts to the take-home pay of union members.

Peter Gelb, the company’s general manager, has said that in order to survive the pandemic and prosper beyond it, the company must cut payroll costs for those unions by 30 percent, effectively cutting take-home pay by about 20 percent. Union leaders have resisted the proposed cuts, arguing that many of its members already went many months without pay.

The discount carrier BoltBus is folding because of low ridership during the pandemic.Credit…Eduardo Munoz/Reuters

BoltBus, the bus service known for offering its passengers Wi-Fi and $1 lottery seats, is shutting down operations indefinitely after months of low ridership during the pandemic, according to Greyhound, its parent company.

The discount bus operator said last month that it was transferring most of its routes to Greyhound in order to “undergo renovations.” BoltBus had suspended service earlier in the pandemic, but its parent company said last week that the operator had no plans to put its buses back on the road.

“Currently there is not a timeline to return BoltBus operations,” Emma Kaiser, a Greyhound spokeswoman, told The Seattle Times.

Greyhound, which operates the largest intercity bus fleet in North America, teamed up with Peter Pan Bus Lines in 2008 to start BoltBus. The companies wanted to offer an affordable ride to people put off by grubbier alternatives.

At least one seat on every BoltBus ride sold for $1 plus a booking fee. Passengers could reserve seats, unlike on Greyhound. BoltBus offered passengers Wi-Fi, individual power outlets and extra legroom, according to its website.

Other cheap intercity bus operators that are still running, including FlixBus, Peter Pan and Megabus, may see a surge in riders, because domestic travel is on the rise as pandemic restrictions loosen.

Credit…Trisha Krauss

Millions of Americans decided that this past year was an opportune time to rip out some walls and build a new kitchen, bathroom or addition.

For those who muscled through and stayed in their homes while the work was underway, the experience was of a 24-7 construction site. With offices closed, conference calls took place against a noisy backdrop of hammering and sanding. So much for Zoom school when the Wi-Fi goes down without warning. Need a quick meal because the kitchen is gutted down to the studs? It’s not so easy when restaurants are closed for indoor dining.

Rajiv Surendra, a calligrapher and actor in his early 30s who is best known for his role in the 2004 movie “Mean Girls,” renovated the kitchen in his Upper West Side one-bedroom last year. He installed wainscoting, sanded cabinets, and made bracket shelves and a peg rail by hand. With his entire apartment turned into a work site, he had almost no space that felt like his own.

So he found something that could mentally take him away from a space he rarely left. Every night, he would spend two hours practicing the harp and the piano, teaching himself Chopin’s Nocturne Op. 9 No. 2. “That was a very good thing, for me to get my mind away from that stuff,” he said.

Categories
Health

F.D.A. Releases One other Batch of Johnson & Johnson’s Vaccine

WASHINGTON — Federal regulators on Friday cleared a batch of vaccine that could furnish up to 15 million doses of Johnson & Johnson’s one-shot coronavirus vaccine, deciding they can be safely distributed despite production failures at the factory that ruined 75 million other doses.

The move brings the total number of Johnson & Johnson doses made at the Baltimore facility and cleared by the Food and Drug Administration for distribution in the United States to roughly 40 million. But Johnson & Johnson remains far short of its commitment to deliver 100 million doses to the federal government by the end of June. European Union officials have said the company is missing its delivery targets there, as well.

The vaccine cleared on Friday is not yet bottled, and the Biden administration’s plans for it remain unclear. But with new coronavirus cases dropping and the country awash in vaccines from two other authorized manufacturers, most new Johnson & Johnson doses produced in the United States are likely destined for export.

Johnson & Johnson has been unable to produce much of its vaccine since April, when regulators shut down the Baltimore factory, operated by Emergent BioSolutions, because of major production errors. Johnson & Johnson had been relying on Emergent, its subcontractor, to produce vaccine for use in the United States as well as to meet its commitments overseas while it expanded its own plant in Leiden, the Netherlands.

Even with the newly cleared batch, Johnson & Johnson remains nearly 40 million doses short of the 100 million doses called for in its federal contract. The F.D.A. did not disclose the precise number of doses cleared Friday, but multiple people familiar with Emergent’s operation said the batch amounted to as many as 15 million doses.

Also on Friday, European regulators approved the reopening of Johnson & Johnson’s Dutch plant, a piece of good news for the company amid its supply woes. “Today’s approval represents progress in expanding our global manufacturing network to supply our Covid-19 vaccine worldwide,” the company said in a statement.

The Baltimore factory is expected to remain shuttered for at least several more weeks while Emergent tries to bring it up to standard, according to people familiar with its operation who spoke on condition of anonymity. The F.D.A. said in a statement Friday that it was not yet ready to certify that the plant was following proper manufacturing practices.

After the discovery in March that Emergent workers had contaminated a batch of Johnson & Johnson’s vaccine with a key ingredient for AstraZeneca’s Covid vaccine being made at the same plant, regulators cited Emergent for a series of regulatory violations. Emergent was forced to throw out the equivalent of 75 million doses of Johnson & Johnson vaccine. European authorities discarded another 17 million more doses, and South Africa, which is desperate for vaccine, pulled two million more.

The Biden administration also had to pivot from relying on AstraZeneca doses to fulfill its pledge to donate vaccine to poorer nations, swapping in supplies from other makers. The F.D.A. has yet to rule on whether the equivalent of more than 100 million doses of both Johnson & Johnson and AstraZeneca vaccines produced by Emergent are suitable for use.

The F.D.A. has been conducting a painstaking review of every vaccine batch from the Emergent plant, matching up records of deviations from manufacturing standards with production lots to determine whether the batches can be released. In a letter to Johnson & Johnson released late Friday, the agency said the batch it was releasing was suitable for distribution even though the factory was not adhering to proper manufacturing practices at the time it was produced.

As deliveries of Johnson & Johnson’s vaccine stalled, the Biden administration ended up relying almost entirely on doses made by Pfizer-BioNTech and Moderna. With the pandemic now waning in the United States, demand for shots has plummeted. Johnson & Johnson has teamed up with the pharmaceutical giant Merck to make more doses, but the factory they intend to use is not expected to start operating until the fall.

Although the Johnson & Johnson vaccine was once considered a game changer in the nation’s vaccination campaign, state health officials have struggled to use up even the limited supply they received in the spring. Roughly 12.5 million people in the United States have taken the vaccine, accounting for a little more than half of the available supply, and millions of doses are set to expire by August. It is still being used in doctors’ offices and at smaller events, state officials said.

Enthusiasm for the Johnson & Johnson vaccine dropped in part because of a federally recommended pause in its use in April after a rare blood-clotting disorder was discovered in a few recipients.

But federal health officials are still hoping that surplus doses of Johnson & Johnson’s vaccine will be useful overseas, where vaccine doses remain desperately scarce. White House officials said this week that some countries had requested the vaccine because it is easier to store and transport than the others, and because some people prefer a one-shot regimen. The vaccine has been deployed in 27 countries so far.

On Thursday, Johnson & Johnson reported that early results of unpublished studies showed that its vaccine was effective against the highly contagious Delta variant, even eight months after inoculation. That was a reassuring finding for those who have gotten the company’s shot.

The news came after earlier data showed Pfizer’s and Moderna’s mRNA vaccines as effective against the Delta variant, which is much more contagious than previous variants and is expected to quickly become the dominant version of the virus in the United States. Because Johnson & Johnson’s vaccine rolled out more slowly, information about its effectiveness against variants has also lagged.